当前位置:首页 - 行情中心 - 翰宇药业(300199) - 财务分析 - 现金流量表

翰宇药业

(300199)

  

流通市值:181.35亿  总市值:214.80亿
流通股本:7.46亿   总股本:8.83亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金467,365,876.09190,318,882.35681,297,265.28440,139,306.89
  收到的税费返还22,231,763.899,311,755.8830,363,482.986,169,638.15
  收到其他与经营活动有关的现金31,203,653.453,279,633.7854,550,693.4555,534,396.69
  经营活动现金流入小计520,801,293.43202,910,272.01766,211,441.71501,843,341.73
  购买商品、接受劳务支付的现金153,272,721.6161,165,570.28176,192,560.68109,474,536.09
  支付给职工以及为职工支付的现金99,381,894.5358,222,746.22154,798,704.99107,780,020.47
  支付的各项税费21,371,195.358,375,020.7637,783,855.3624,207,619.42
  支付其他与经营活动有关的现金89,630,913.6434,721,639.43232,730,660.13172,311,552.72
  经营活动现金流出小计363,656,725.13162,484,976.69601,505,781.16413,773,728.7
  经营活动产生的现金流量净额157,144,568.340,425,295.32164,705,660.5588,069,613.03
二、投资活动产生的现金流量:
  收回投资收到的现金2,565,285.573,563,891.74910,000-
  取得投资收益收到的现金115,210,205.25614,700.24
  处置固定资产、无形资产和其他长期资产收回的现金净额8,690182,317.1645,526,00045,526,000
  处置子公司及其他营业单位收到的现金净额1,454,988.23---
  投资活动现金流入小计4,028,964.83,746,209.951,646,205.2546,140,700.24
  购建固定资产、无形资产和其他长期资产支付的现金77,225,384.2133,839,355.58115,835,382.870,216,778.32
  投资支付的现金442,850442,8505,820,0004,650,000
  投资活动现金流出小计77,668,234.2134,282,205.58121,655,382.874,866,778.32
  投资活动产生的现金流量净额-73,639,269.41-30,535,995.68-70,009,177.55-28,726,078.08
三、筹资活动产生的现金流量:
  吸收投资收到的现金--2,592,8502,242,850
  其中:子公司吸收少数股东投资收到的现金--450,000-
  取得借款收到的现金717,157,32070,000,0001,331,433,675.151,041,433,675.15
  收到其他与筹资活动有关的现金36,000,000-197,656,660.08197,656,660.08
  筹资活动现金流入小计753,157,32070,000,0001,531,683,185.231,241,333,185.23
  偿还债务支付的现金490,600,694.3493,916,149.341,540,230,183.421,206,391,071.42
  分配股利、利润或偿付利息支付的现金40,531,500.0520,242,960.64111,745,664.2676,101,816.83
  支付其他与筹资活动有关的现金30,007,562.145,918,849.6225,184,839.04224,689,839.04
  筹资活动现金流出小计561,139,756.53120,077,959.581,877,160,686.721,507,182,727.29
  筹资活动产生的现金流量净额192,017,563.47-50,077,959.58-345,477,501.49-265,849,542.06
四、汇率变动对现金及现金等价物的影响1,822,042.821,595,530.553,377,635.211,998,721.31
五、现金及现金等价物净增加额277,344,905.18-38,593,129.39-247,403,383.28-204,507,285.8
  加:期初现金及现金等价物余额92,532,843.1692,532,843.16339,936,226.44339,936,226.44
  期末现金及现金等价物余额369,877,748.3453,939,713.7792,532,843.16135,428,940.64
补充资料:
  净利润144,519,356.92--180,091,957.93-
  资产减值准备1,411,875.22-108,115,270.24-
  固定资产和投资性房地产折旧52,629,674.34-119,111,796.21-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧52,629,674.34-119,111,796.21-
  无形资产摊销13,796,065.89-28,330,541.83-
  长期待摊费用摊销2,977,821.04-2,648,330.28-
  处置固定资产、无形资产和其他长期资产的损失-552,485.01--42,783,695.52-
  固定资产报废损失8,923.37-57,426.04-
  公允价值变动损失-215,783.62---
  财务费用53,099,662.24-117,779,730.62-
  投资损失-936,950.62--1,545,907.41-
  递延所得税5,309,420.83--383,102.71-
  其中:递延所得税资产减少2,520,469.81--4,213,661.83-
    递延所得税负债增加2,788,951.02-3,830,559.12-
  存货的减少-17,596,681.08--80,073,261.94-
  经营性应收项目的减少-59,001,749.93-26,371,064.88-
  经营性应付项目的增加-40,999,140.66-78,321,565.85-
  其他---16,532,734.2-
  现金的期末余额369,877,748.34-92,532,843.16-
  减:现金的期初余额92,532,843.16-339,936,226.44-
  现金及现金等价物的净增加额277,344,905.18--247,403,383.28-
公告日期2025-08-222025-04-262025-04-262024-10-30
审计意见(境内)标准无保留意见
TOP↑